REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/29/2026
Back to search
Official data from USPTO
HHHBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/29/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
07/10/2020
Registration date
06/29/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/29/2021
Last transaction
06/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
16
Owner location
KR
Examiner
KETCHUM, BRENDAN J
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized word "HHHBio" which consists of the three overlapped "H"s connected to "B" in green and "i" and "o" in red.
Holders and representatives
Holders
3H Bio. Co., Ltd.
Representatives
Paul G. Johnson Maschoff Brennan
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drugs for medical purposesdrugs for the treatment of oncological and metabolic diseases and disorders; medicines for human purposesmedicine for the treatment of infectious diseases; medicines for human purposesmedicine for the treatment of viral diseases and disorders; medicines for human purposesmedicine for the treatment of respiratory diseases and disorders; therapeutic drugs and agentstherapeutic drugs for the treatment of immune system related diseases and disorders; pharmaceutical preparations for preventing and treating obesity; vaccines; human vaccine preparations; pharmaceutical agents affecting metabolism; protein for medical purposesprotein arrays for diagnosing cancer; protein for medical purposesprotein arrays for diagnosing allergies; peptide for medical purposessynthetic peptides for the treatment of immune system related diseases and disorders; synthetic protein for the treatment of diabetes; synthetic protein for the treatment of oncological and metabolic diseases and disorders; synthetic peptide for the treatment of obesity; synthetic peptide for the treatment of viral diseases and disorders; pharmaceutical preparations containing peptides as the active ingredientspharmaceutical preparations for the treatment of neurological diseases and disorders
Class 42
Research relating to pharmaceuticalspharmaceutical research services; medicine researchresearch and development of medicines; medical analysis services of peptide for the treatment of people; research for medical productsnamely medical research; chemical research; biological research; laboratory research in the field of pharmaceuticals; clinical studies of medicinesconducting clinical trials for others; operation of medical laboratorymedical laboratory services; scientific research for medical purposes; research and development of peptide for medical purposes; research of biology; research and development of peptide for scientific or laboratory purposes; drug discovery services; research and development of technology for biotechnology; development of pharmaceutical preparations and medicines
Publications
History of USPTO decisions and trademark events.
27 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/28/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/28/2021
FIMP
FINAL DISPOSITION PROCESSED
10/28/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/29/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/29/2021
GPNX
NOTIFICATION PROCESSED BY IB
04/13/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/13/2021
PUBO
PUBLISHED FOR OPPOSITION
04/13/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/24/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/24/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/24/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2021
RFNT
REFUSAL PROCESSED BY IB
03/01/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/05/2021
RFRR
REFUSAL PROCESSED BY MPU
02/05/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/20/2021
CNRT
NON-FINAL ACTION WRITTEN
01/19/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/16/2021
DOCK
ASSIGNED TO EXAMINER
01/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/12/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/11/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/24/2020
Continuous trademark protection
Get notified about every new filing that threatens HHHBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.